Abstract
Europrise is a Network of Excellence supported by the European Commission within the 6th Framework programme from 2007 to 2012. The Network has involved over 50 institutions from 13 European countries together with 3 industrial partners and 6 African countries. The Network encompasses an integrated program of research, training, dissemination and advocacy within the field of HIV vaccines and microbicides. A central and timely theme of the Network is the development of the unique concept of co-usage of vaccines and microbicides. Training of PhD students has been a major task, and some of these post-graduate students have here summarized novel ideas emanating from presentations at the last annual Europrise meeting in Prague. The latest data and ideas concerning HIV vaccine and microbicide studies are included in this review; these studies are so recent that the majority have yet to be published. Data were presented and discussed concerning novel immunisation strategies; microbicides and PrEP (alone and in combination with vaccines); mucosal transmission of HIV/SIV; mucosal vaccination; novel adjuvants; neutralizing antibodies; innate immune responses; HIV/SIV pathogenesis and disease progression; new methods and reagents. These - necessarily overlapping and thought-provoking topics - are comprehensively summarised by the Europrise students in the context of other recent exciting data.
| Original language | English |
|---|---|
| Pages (from-to) | 144 |
| Number of pages | 1 |
| Journal | Journal of Translational Medicine |
| DOIs | |
| Publication status | Accepted/In press - Jul 11 2012 |
Fingerprint
ASJC Scopus subject areas
- Medicine(all)
- Biochemistry, Genetics and Molecular Biology(all)
Cite this
Rational design of HIV vaccines and microbicides : Report of the EUROPRISE annual conference 2011. / Ruffin, Nicolas; Borggren, Marie; Euler, Zelda; Fiorino, Fabio; Grupping, Katrijn; Hallengärd, David; Javed, Aneele; Mendonca, Kevin; Pollard, Charlotte; Reinhart, David; Saba, Elisa; Sheik-Khalil, Enas; Sköld, Annette; Ziglio, Serena; Scarlatti, Gabriella; Gotch, Frances; Wahren, Britta; Shattock, Robin J.
In: Journal of Translational Medicine, 11.07.2012, p. 144.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Rational design of HIV vaccines and microbicides
T2 - Report of the EUROPRISE annual conference 2011
AU - Ruffin, Nicolas
AU - Borggren, Marie
AU - Euler, Zelda
AU - Fiorino, Fabio
AU - Grupping, Katrijn
AU - Hallengärd, David
AU - Javed, Aneele
AU - Mendonca, Kevin
AU - Pollard, Charlotte
AU - Reinhart, David
AU - Saba, Elisa
AU - Sheik-Khalil, Enas
AU - Sköld, Annette
AU - Ziglio, Serena
AU - Scarlatti, Gabriella
AU - Gotch, Frances
AU - Wahren, Britta
AU - Shattock, Robin J.
PY - 2012/7/11
Y1 - 2012/7/11
N2 - Europrise is a Network of Excellence supported by the European Commission within the 6th Framework programme from 2007 to 2012. The Network has involved over 50 institutions from 13 European countries together with 3 industrial partners and 6 African countries. The Network encompasses an integrated program of research, training, dissemination and advocacy within the field of HIV vaccines and microbicides. A central and timely theme of the Network is the development of the unique concept of co-usage of vaccines and microbicides. Training of PhD students has been a major task, and some of these post-graduate students have here summarized novel ideas emanating from presentations at the last annual Europrise meeting in Prague. The latest data and ideas concerning HIV vaccine and microbicide studies are included in this review; these studies are so recent that the majority have yet to be published. Data were presented and discussed concerning novel immunisation strategies; microbicides and PrEP (alone and in combination with vaccines); mucosal transmission of HIV/SIV; mucosal vaccination; novel adjuvants; neutralizing antibodies; innate immune responses; HIV/SIV pathogenesis and disease progression; new methods and reagents. These - necessarily overlapping and thought-provoking topics - are comprehensively summarised by the Europrise students in the context of other recent exciting data.
AB - Europrise is a Network of Excellence supported by the European Commission within the 6th Framework programme from 2007 to 2012. The Network has involved over 50 institutions from 13 European countries together with 3 industrial partners and 6 African countries. The Network encompasses an integrated program of research, training, dissemination and advocacy within the field of HIV vaccines and microbicides. A central and timely theme of the Network is the development of the unique concept of co-usage of vaccines and microbicides. Training of PhD students has been a major task, and some of these post-graduate students have here summarized novel ideas emanating from presentations at the last annual Europrise meeting in Prague. The latest data and ideas concerning HIV vaccine and microbicide studies are included in this review; these studies are so recent that the majority have yet to be published. Data were presented and discussed concerning novel immunisation strategies; microbicides and PrEP (alone and in combination with vaccines); mucosal transmission of HIV/SIV; mucosal vaccination; novel adjuvants; neutralizing antibodies; innate immune responses; HIV/SIV pathogenesis and disease progression; new methods and reagents. These - necessarily overlapping and thought-provoking topics - are comprehensively summarised by the Europrise students in the context of other recent exciting data.
UR - http://www.scopus.com/inward/record.url?scp=84863565487&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84863565487&partnerID=8YFLogxK
U2 - 10.1186/1479-5876-10-144
DO - 10.1186/1479-5876-10-144
M3 - Article
C2 - 22784600
AN - SCOPUS:84863565487
SP - 144
JO - Journal of Translational Medicine
JF - Journal of Translational Medicine
SN - 1479-5876
ER -